Bare Financial Services
MYGN icon

Bare Financial Services’s Myriad Genetics MYGN Stock Holding History

Bare Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-184
Closed -$1.05K – 1960
2026
Q2 		$1.05K Buy
184
+98
+114% +$445 ﹤0.01% 1359
2026
Q1 		$387 Buy
86
+31
+56% +$162 ﹤0.01% 1668
2025
Q4 		$338 Hold
55
– – ﹤0.01% 1515
2025
Q3 		$398 Sell
55
-374
-87% -$2.22K ﹤0.01% 1374
2025
Q2 		$2.28K Buy
429
+334
+352% +$1.97K ﹤0.01% 730
2025
Q1 		$843 Buy
+95
New +$1.14K ﹤0.01% 585

Other funds holding MYGN

Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return

Bare Financial Services's MYGN Position: Q3 2026 in Review

Bare Financial Services sold out of Myriad Genetics (MYGN) in Q3 2026, closing a stake of 184 shares — an estimated $1.05K sold.

Bare Financial Services first reported a position in MYGN in Q1 2025 and held it in 6 quarters. The position peaked at $2.28K in Q2 2025. 42 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Bare Financial Services reported no remaining Myriad Genetics position as of Q3 2026 after selling out during the quarter.
  • Bare Financial Services sold 184 Myriad Genetics shares in Q3 2026, an estimated $1.05K.
  • Bare Financial Services first reported a position in Myriad Genetics in Q1 2025 and held it in 6 quarters.
  • Bare Financial Services's Myriad Genetics position peaked at $2.28K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.